New study documents functional extinction of two critically endangered coral species following record heatwave in Florida
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Nov-2025 01:11 ET (2-Nov-2025 06:11 GMT/UTC)
Evolutionary biologists have long believed that the human-biting mosquito, Culex pipiens form molestus, evolved from the bird-biting form, Culex pipiens form pipiens, in subways and cellars in northern Europe over the past 200 years. It’s been held up as an example of a species’ ability to rapidly adapt to new environments and urbanization. Now, a new study led by Princeton University researchers disproves that theory, tracing the origins of the molestus mosquito to more than 1,000 years ago in the Mediterranean or Middle East. The researchers collected and sequenced the genomes of about 800 mosquitoes with both genetic and geographic diversity, including the ancestral bird-biting form. The Cx. pipiens form pipiens is a major source of West Nile virus. Studying both forms of the mosquito and their evolution allowed the researchers to better understand when and where hybridization, or the flow of genes from human-biting molestus into bird-biting pipiens occurs today, which is thought to have led to increased transmission of West Nile virus to humans over the past two decades.
Scientists have known hormone-sensitive lipase (HSL) as the enzyme that releases energy stored in our fat. Yet patients born without this protein do not become obese : on the contrary, they lose their adipose tissue, developing lipodystrophy with severe metabolic complications. A team from the Institute of Metabolic and Cardiovascular Diseases (I2MC, Inserm/Université de Toulouse) has just solved this puzzle by discovering that HSL plays a second, unsuspected role in the nucleus of fat cells, published online in Cell Metabolism on October 23.
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.